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Background
A vast majority of asthma exacerbations are linked to
viral infections, most of which are caused by rhinovirus
(RV). We hypothesize that eosinophils are key effector
cells in asthma exacerbations. As such, using an in vitro
model of human cells, we have shown that respiratory
syncytial virus (RSV) and RV induce eosinophil degranu-
lation when co-cultured with T-cells and autologous
monocyte-derived dendritic cells (moDC), concurrent
with moDC-dependent CD4+ CD45RO+ T-cell activa-
tion. While our original hypothesis has been that such
activation is mediated solely by antigen-presentation
(AP), our recent data also suggest that RV may be the
major pathogen associated with asthma attacks because
of its unique ability to interact directly with T-cells.
Materials and methods
Human monocytes, T-lymphocytes, autologous moDC
and eosinophils (EOS) were isolated from blood. moDC
were cultured with RSV, RV, or sham, then washed, and
incubated with autologous T-cells. To determine the
role for antigen presentation, some moDC were treated
with the inhibitor chloroquine before virus culture. In
some, no moDc were added and T lymphocytes (CD4,
CD8 or a mix) were exposed to RSV, RV or UV-inacti-
vated RV (RV-UV). T-cell activation and apoptosis were
measured by flow cytometry (CD25 expression and
Annexin-V/TO-PRO-3 staining, respectively), and prolif-
eration by BrdU incorporation (Cell Proliferation ELISA,
Roche). EOS cysteinyl-leukotriene (Cys-LT) release was
measured by ELISA (Cayman Chemical). Cytokine
release was measured by Searchlight (Pierce).
Results
RV presence induced a 5-fold increase in Cys-LT release
from EOS co-cultured with T-cells and moDC, while
RSV did not have any effect. In T-cell and moDC co-
cultures, RV induced greater increases in IL-1beta, IL-
10, IL-12p70, IL-13 and IFN-gamma compared with
RSV. T-cells, and more evidently CD8+ T-cells, showed
increased apoptosis when incubated with RV but not
with RV-UV or RSV. Virus-loaded moDC induced pro-
liferation of T-cells, but, unlike RSV, RV was insensitive
to chloroquine.
Conclusions
Our results suggest that RSV and RV induce EOS and
T-cell activation differentially. RSV induces proliferation
in a MHC-II restricted antigen-presentation-dependent
m a n n e r ,w h i l ef o rR Vt h i si sn o tt h es o l ep a t h w a y .I n
addition, based on cytokine and Cys-LT release, RV
appears to be more potent compared to RSV. Our data
are relevant to help understand why RV is so potent in
the induction of asthma exacerbation in allergic patients,
and will lead to novel potential targets for improved
preventative strategies.
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